| 1 |
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine
Open access |
13 Jun 2016 |
7,629 |
| 2 |
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al. · Diabetes Care
Open access |
8 Jun 2019 |
4,012 |
| 3 |
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
S. E. Inzucchi, Richard M. Bergenstal, John B. Buse et al. · Diabetologia
Open access |
19 Apr 2012 |
3,934 |
| 4 |
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse et al. · Diabetes Care
Open access |
19 Apr 2012 |
3,225 |
| 5 |
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse et al. · Diabetes Care
Open access |
13 Dec 2014 |
3,098 |
| 6 |
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh et al. · Arthritis & Rheumatology
|
6 Nov 2015 |
2,810 |
| 7 |
Complications of Endoscopic Biliary Sphincterotomy
Martin L. Freeman, Douglas B. Nelson, Stuart Sherman et al. · New England Journal of Medicine
Open access |
26 Sep 1996 |
2,570 |
| 8 |
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
William B. White, Christopher Paul Cannon, Simon R. Heller et al. · New England Journal of Medicine
Open access |
2 Sep 2013 |
2,539 |
| 9 |
Diabetes and Cancer
Edward L. Giovannucci, David M. Harlan, Michael C. Archer et al. · Diabetes Care
Open access |
29 Jun 2010 |
2,267 |
| 10 |
International Consensus on Use of Continuous Glucose Monitoring
Thomas Danne et al. · Diabetes Care
Open access |
10 Nov 2017 |
2,082 |
| 11 |
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Nicole C. Foster, Roy W. Beck, Kellee M. Miller et al. · Diabetes Technology & Therapeutics
Open access |
18 Jan 2019 |
1,925 |
| 12 |
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
Jasvinder A. Singh et al. · Arthritis Care & Research
Open access |
2 Apr 2012 |
1,806 |
| 13 |
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
Faramarz Ismail‐Beigi et al. · The Lancet
Open access |
Jul 2010 |
1,434 |
| 14 |
Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
Elizabeth R. Seaquist, John E. Anderson, Belinda P. Childs et al. · Diabetes Care
Open access |
13 Apr 2013 |
1,404 |
| 15 |
Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry
Kellee M. Miller, Nicole C. Foster, Roy W. Beck et al. · Diabetes Care
|
12 May 2015 |
1,264 |
| 16 |
Diabetes and Cancer: A Consensus Report
Edward L. Giovannucci, David M. Harlan, Michael C. Archer et al. · CA A Cancer Journal for Clinicians
Open access |
16 Jun 2010 |
1,071 |
| 17 |
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study
D. E Bonds, M. E Miller, RM Bergenstal et al. · BMJ
Open access |
8 Jan 2010 |
934 |
| 18 |
Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma
Sagar Lonial, Susanna Joan Jacobus, RAFAEL RICARDO AURELIANO DA FONSECA et al. · Journal of Clinical Oncology
Open access |
25 Oct 2019 |
909 |
| 19 |
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Richard M. Bergenstal, William V. Tamborlane, Andrew Ahmann et al. · New England Journal of Medicine
Open access |
29 Jun 2010 |
899 |
| 20 |
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
Jay S. Skyler, Richard M. Bergenstal, Robert O. Bonow et al. · Diabetes Care
Open access |
17 Dec 2008 |
887 |
| 21 |
Detection of Huntington's disease decades before diagnosis: the Predict-HD study
Jane S. Paulsen, Douglas R. Langbehn, Julie C. Stout et al. · Journal of Neurology Neurosurgery & Psychiatry
Open access |
20 Dec 2007 |
818 |
| 22 |
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Tadej Battelino et al. · The Lancet Diabetes & Endocrinology
Open access |
6 Dec 2022 |
811 |
| 23 |
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
Roy W. Beck, Richard M. Bergenstal, Tonya D. Riddlesworth et al. · Diabetes Care
Open access |
23 Oct 2018 |
794 |
| 24 |
Derivation of the sledai
Eric S. Schned, Scott L. Glickstein, Molly Doyle · Arthritis & Rheumatism
|
Jun 1993 |
727 |
| 25 |
Hereditary Diffuse Gastric Cancer Syndrome
Samantha Hansford et al. · JAMA Oncology
Open access |
12 Feb 2015 |
701 |
| 26 |
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse et al. · Diabetologia
Open access |
12 Jan 2015 |
699 |
| 27 |
Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring
Richard M. Bergenstal, Roy W. Beck, Kelly L. Close et al. · Diabetes Care
Open access |
17 Sep 2018 |
693 |
| 28 |
Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia
Richard M. Bergenstal, David Charles Klonoff, Satish K. Garg et al. · New England Journal of Medicine
Open access |
22 Jun 2013 |
653 |
| 29 |
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections
Roy W. Beck, Tonya D. Riddlesworth, Katrina J. Ruedy et al. · Annals of Internal Medicine
|
19 Sep 2017 |
629 |
| 30 |
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
Richard M. Bergenstal, Carol Wysham, Leigh MacConell et al. · The Lancet
|
29 Jun 2010 |
608 |
| 31 |
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin
Thomas W. Martens et al. · JAMA
Open access |
3 Jun 2021 |
531 |
| 32 |
Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes
John B. Buse, Richard M. Bergenstal, Leonard C. Glass et al. · Annals of Internal Medicine
|
18 Jan 2011 |
508 |
| 33 |
Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants
Kellee M. Miller, Roy W. Beck, Richard M. Bergenstal et al. · Diabetes Care
Open access |
2 Feb 2013 |
507 |
| 34 |
Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics
Margaret A. Powers, Joan K. Bardsley, Marjorie Cypress et al. · Diabetes Care
|
5 Jun 2015 |
504 |
| 35 |
The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading
Roy W. Beck, Crystal G. Connor, Deborah M. Mullen et al. · Diabetes Care
Open access |
11 Jul 2017 |
479 |
| 36 |
The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c
Roy W. Beck, Richard M. Bergenstal, Peiyao Cheng et al. · Journal of Diabetes Science and Technology
Open access |
13 Jan 2019 |
473 |
| 37 |
The T1D Exchange Clinic Registry
Roy W. Beck, William V. Tamborlane, Richard M. Bergenstal et al. · The Journal of Clinical Endocrinology & Metabolism
|
21 Sep 2012 |
464 |
| 38 |
Epidemiology of Vertebral Fractures
John T. Schousboe · Journal of Clinical Densitometry
|
5 Sep 2015 |
451 |
| 39 |
Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical Practice
David Tanné, Scott Eric Kasner, Andrew M. Demchuk et al. · Circulation
Open access |
9 Apr 2002 |
435 |
| 40 |
The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study
M. E Miller, D. E Bonds, Hertzel C. Gerstein et al. · BMJ
Open access |
8 Jan 2010 |
431 |
| 41 |
Diabetes Self-management Education and Support in Type 2 Diabetes
Margaret A. Powers, Joan K. Bardsley, Marjorie Cypress et al. · The Science of Diabetes Self-Management and Care
|
5 Jun 2015 |
408 |
| 42 |
Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease
Michael Jan Shaw, Nicholas Joseph Talley, Timothy J. Beebe et al. · The American Journal of Gastroenterology
Open access |
2001 |
408 |
| 43 |
Structural Racism and Supporting Black Lives — The Role of Health Professionals
Rachel R. Hardeman, Eduardo Luis Manzanares Medina, Katy Backes Kozhimannil · New England Journal of Medicine
Open access |
12 Oct 2016 |
402 |
| 44 |
Outcomes After Complete Versus Incomplete Revascularization of Patients With Multivessel Coronary Artery Disease
Santiago Antuel García, Yader B. Sandoval, Henri Roukoz et al. · Journal of the American College of Cardiology
Open access |
7 Jun 2013 |
396 |
| 45 |
Subclinical Thyroid Dysfunction: A Joint Statement on Management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society
Hossein Gharib, Robert Michael Tuttle, H. Jack Baskin et al. · The Journal of Clinical Endocrinology & Metabolism
|
2005 |
395 |
| 46 |
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes
Richard E. Pratley et al. · JAMA
Open access |
16 Jun 2020 |
372 |
| 47 |
Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial
Craig A. Solem, Edward V. Loftus, Joel G. Fletcher et al. · Gastrointestinal Endoscopy
Open access |
3 Jun 2008 |
372 |
| 48 |
Severe Hypoglycemia and Diabetic Ketoacidosis in Adults With Type 1 Diabetes: Results From the T1D Exchange Clinic Registry
Ruth S. Weinstock, Dongyuan Xing, David M. Maahs et al. · The Journal of Clinical Endocrinology & Metabolism
|
12 Jun 2013 |
342 |
| 49 |
Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
David L Russell-Jones, Robert M Cuddihy, M Hanefeld et al. · Diabetes Care
Open access |
30 Dec 2011 |
341 |
| 50 |
Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients With Coronary Artery Disease
Mark S. Wathen, Michael O. Sweeney, Paul DeGroot et al. · Circulation
Open access |
14 Aug 2001 |
333 |